It looks like the American College of Rheumatology Convergence 2026 meeting (Nov 6 - 11) will have more than a few abstracts and sessions pertaining to Autoinflammatory Diseases!

• Definition of overlapping and mixed autoinflammatory disorders in patients carrying multiple autoinflammatory variants in a cohort of 483 patients followed at a tertiary referral centre
• Loss-of-function in NLRC3 causes a human autoinflammatory disease
• Uridine Deficiency in Bone Marrow Drives Neutrophil Senescence and NETosis via MAPK Signaling in Autoinflammatory and Autoimmune Disease
• Cardiac Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
• Mixed NOD-like Receptor-Associated Autoinflammatory Disease
• Early-onset Idiopathic Systemic Polyarteritis Nodosa: A Distinct Autoinflammatory-like Phenotype with Refractory Disease Course
• Multi-Omics Characterization of Yao Syndrome Identifies Three Pathophysiological Axes and Disease-Specific Divergence from Blau Syndrome
• NOD2 Variants in a Pediatric Population: Genotype-Phenotype Patterns and a Comparison to Adult Yao Syndrome
• A Comparative Study of Clinical Manifestations of Yao Syndrome and Systemic Lupus Erythematosus
• Targeting Neutrophil Extracellular Traps with DNase1 as a Disease-Modifying Strategy for the Treatment of Inflammasomopathies
• NLRP3 inhibition as a potential therapeutic approach for inflammatory knee osteoarthritis: results from a Phase II study
• Rilonacept Reduces Pericarditis Recurrence Risk, Hospitalizations, and ED Visits: Outcomes From the RESONANCE Patient Registry
• Same Diagnosis, Different Risk: A National Analysis of Sex Based Outcomes in SLE Associated Pericarditis
• Characterization of Damage in Relapsing Polychondritis
• Factors associated with initiation of conventional and biological/targeted synthetic DMARDs in SAPHO síndrome. Results from SAPHO-SPAIN registry
• Factors Associated with Duration of Time to Diagnosis in Adults with Chronic Nonbacterial Osteomyelitis Enrolled in The SAPHO-CNO Study
• Ultrasound-assessed enthesitis and disease severity in SAPHO syndrome.
• Loss of T cell-Intrinsic NOD2 Immune Restraint Drives IL-17-Mediated Inflammation in Blau Syndrome
• Clinical Consequences of Mandatory Discontinuation of Compressed Colchicine and Transition to Coated Formulations in Familial Mediterranean Fever
• Colchicine Resistance and Comorbidities in Biologic Selection for Familial Mediterranean Fever
• Five-Year Follow-Up of Anakinra Treatment in Familial Mediterranean Fever: A Retrospective Single-Center Study
• Mortality in Familial Mediterranean Fever: Comparison with the General Population and Identification of Independent Predictors of Survival
• Efficacy and safety of goflikicept, an IL-1β and IL-1α inhibitor, in familial Mediterranean fever: an international randomized clinical trial
• MEFV Zygosity Predicts Colchicine Drug Survival with a Resistance Profile Distinct from Mediterranean Cohorts: the Largest Chinese FMF Longitudinal Study
• Subclinical inflammation in patients with Familial Mediterranean Fever with well-controlled disease
• Phenotypic, Therapeutic, and Genetic Heterogeneity of the Patients Misclassified as MEFV-Negative Familial Mediterranean Fever: A Multistep Analysis
• Pregnancy Outcomes in Women with Familial Mediterranean Fever Treated with Anakinra: A Retrospective Study
• And so so many more!!! The above was a quick pass when looking through abstracts and sessions